Andrea S. Blevins Primeau, PhD, MBA

All articles by Andrea S. Blevins Primeau, PhD, MBA

September 23, 2022

Neoadjuvant plus adjuvant pembrolizumab can prolong event-free survival vs adjuvant pembrolizumab alone in resectable melanoma.

September 7, 2022

Exposure to low-dose methotrexate is associated with an increased risk of melanoma, according to a meta-analysis of 17 studies.

July 20, 2022

Race and ethnicity were reported in less than 25% of the trials studied.

June 6, 2022

Researchers sought to determine the impact of body changes on pediatric patients who undergo treatment for AML.

Next post in General Medicine